The Editors have retracted this article titled “HMGB2 upregulation promotes the progression of hepatocellular carcinoma cells through the activation of ZEB1/vimentin axis” (1) published in Journal of Gastrointestinal Oncology based on concerns about some of the data presented in this article, which were brought to the attention of the Editors. Specifically, the image panel of some figures appears to overlap with the some figure images of the article published in Oncotarget (2). After reviewing the raw data files provided by the authors, the Editors no longer have confidence in the reliability of the findings and conclusions presented in this manuscript.
The authors did not respond to correspondence from the Publisher regarding this retraction.
References
- 1.Lu K, Zhao T, Yang L, et al. HMGB2 upregulation promotes the progression of hepatocellular carcinoma cells through the activation of ZEB1/vimentin axis. J Gastrointest Oncol 2023;14:2178-91. 10.21037/jgo-23-447 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 2.Sun B, Hu C, Yang Z, et al. Midkine promotes hepatocellular carcinoma metastasis by elevating anoikis resistance of circulating tumor cells. Oncotarget 2017;8:32523-35. 10.18632/oncotarget.15808 [DOI] [PMC free article] [PubMed] [Google Scholar]